- AbbVie Inc. is a leading global biopharmaceutical company headquartered in North Chicago, Illinois, specializing in immunology, oncology, and neuroscience, with a market cap of $360.2 billion and a diverse portfolio that includes key products like HUMIRA, SKYRIZI, and RINVOQ.
- In the past year, AbbVie reported full-year net revenues of $61.160 billion for 2025, marking an 8.6% increase, and showcased late-breaking Phase 2 data for its oncology product ELAHERE® at SGO 2026, indicating ongoing investment in R&D and product development.
- AbbVie has established significant revenue streams from its immunology portfolio, generating $30.406 billion in 2025, with strong performances from products like Skyrizi and Rinvoq, highlighting its partnerships with healthcare providers and institutions.
- Sales teams should focus on AbbVie now as they navigate patent expirations and competitive pressures, positioning their innovative therapies as solutions for healthcare providers seeking effective treatments in immunology and oncology.
AbbVie employs a diverse workforce across 19 departments, with a significant concentration in Operations, Sales, and Information Technology. The Operations department leads with 3,686 employees, followed closely by Sales at 2,801 and Information Technology with 2,349 staff members. This distribution reflects a strong emphasis on both operational efficiency and technological advancement, while also highlighting the importance of sales in driving company growth.
AbbVie has a widespread geographic presence with 1,107 locations, primarily concentrated in Illinois. The largest site is in North Chicago, housing 3,936 employees, followed by Lake Forest with 2,682 staff. The substantial headcount in 'Other' locations, totaling 14,281, indicates a distributed workforce that supports various operational needs across multiple regions, enhancing the company's ability to adapt to local market demands.
